These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 10794093

  • 1. Experience with PCR screening.
    Sun R, Jayakar H, Yeh S, Mendoza M, Wisbeski MH, Iszczyszyn W, Dragon EA.
    Dev Biol (Basel); 2000; 102():81-91. PubMed ID: 10794093
    [Abstract] [Full Text] [Related]

  • 2. Performance characteristics of the AmpliScreen HIV-1 test, an assay designed for screening plasma mini-pools.
    Yang Y, Wisbeski MH, Mendoza M, Dorf S, Xu D, Nguyen M, Yeh S, Sun R.
    Biologicals; 1999 Dec; 27(4):315-23. PubMed ID: 10686058
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT.
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.
    Sun R, Schilling W, Jayakar H, Ku J, Wang J, Rosenstraus M, Spadoro J.
    Transfusion; 1999 Oct; 39(10):1111-9. PubMed ID: 10532606
    [Abstract] [Full Text] [Related]

  • 6. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A.
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [Abstract] [Full Text] [Related]

  • 7. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 8. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P, Wessberg S, Tuomi K, Laitinen H.
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [Abstract] [Full Text] [Related]

  • 9. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C.
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [Abstract] [Full Text] [Related]

  • 12. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [Abstract] [Full Text] [Related]

  • 13. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ.
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Performance characteristics of the COBAS AmpliScreen HIV-1 test, version 1.5, an assay designed for screening plasma mini-pools.
    Yang Y, Lamendola MH, Mendoza M, Xu D, Nguyen M, Yeh S, Wu Y, Ku J, Rosenstraus M, Sun R.
    Transfusion; 2001 May; 41(5):643-51. PubMed ID: 11346701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [Abstract] [Full Text] [Related]

  • 20. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM, Chudy M, Volkers P, Löwer J.
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.